40 Recruiting Breast Cancer Clinical Trials in Alabama
Explore active breast cancer research studies enrolling across Alabama. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Breast Cancer Studies in Alabama
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
📍 Regional Medical Center — Anniston, Alabama
View Study & Checklist ➔Understanding and Predicting Breast Cancer Events After Treatment
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Breast Cancer Index (BCI) Registry
📍 Southern Cancer Center, P.C. - Daphne — Daphne, Alabama
View Study & Checklist ➔Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
📍 Research Site — Anchorage, Alabama
View Study & Checklist ➔Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
📍 University of Alabama Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
📍 University of Alabama - Birmingham — Birmingham, Alabama
View Study & Checklist ➔Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
📍 Dothan Hematology and Oncology — Dothan, Alabama
View Study & Checklist ➔Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
📍 Research Site — Daphne, Alabama
View Study & Checklist ➔The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
📍 University of Alabama - Birmingham — Birmingham, Alabama
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
📍 Southern Cancer Center, PC ( Site 8003) — Daphne, Alabama
View Study & Checklist ➔Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
📍 University of Alabama Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Male Breast Cancer: Understanding the Biology for Improved Patient Care
📍 University Of Alabama Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔PALbociclib CoLlaborative Adjuvant Study
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
📍 Alabama Oncology — Birmingham, Alabama
View Study & Checklist ➔Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
📍 The Kirklin Clinic of UAB Hospital — Birmingham, Alabama
View Study & Checklist ➔Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
📍 Birmingham Hematology Associates — Birmingham, Alabama
View Study & Checklist ➔A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
📍 Southern Cancer Center, PC — Daphne, Alabama
View Study & Checklist ➔MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
📍 CHS Grandview — Birmingham, Alabama
View Study & Checklist ➔Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
📍 University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center (HSROC) — Birmingham, Alabama
View Study & Checklist ➔TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
📍 Southern Cancer Center, PC — Daphne, Alabama
View Study & Checklist ➔Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
📍 Southern Cancer Center — Mobile, Alabama
View Study & Checklist ➔A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
📍 Research Site — Daphne, Alabama
View Study & Checklist ➔Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
📍 University of Alabama, Birmingham — Birmingham, Alabama
View Study & Checklist ➔Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
📍 The University of Alabama — Birmingham, Alabama
View Study & Checklist ➔Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
📍 The Kirklin Clinic — Birmingham, Alabama
View Study & Checklist ➔An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
📍 University of Alabama At Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔